Primary Site >> Colorectal Cancer

Gene >> BCL2A1

Journal: Cancer Causes Control. 2013 Dec;24(12):2077-87.
Title: Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.
Author: Prizment, Anna E|Folsom, Aaron R|Dreyfus, Jill|Anderson, Kristin E|Visvanathan, Kala|Joshu, Corinne E|Platz, Elizabeth A|Pankow, James S
PMID: 24036889
Journal: PLoS One. 2014 Mar 26;9(3):e92212.
Title: Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer.
Author: Hiraki, Linda T|Joshi, Amit D|Ng, Kimmie|Fuchs, Charles S|Ma, Jing|Hazra, Aditi|Peters, Ulrike|Karlson, Elizabeth W|Giovannucci, Edward|Kraft, Peter|Chan, Andrew T
PMID: 24670869
Journal: Oncol Lett. 2015 Feb;9(2):967-971.
Title: MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2.
Author: Wang, Tairen|Li, Fei|Tang, Shengjian
PMID: 25621074
Journal: Int J Cancer. 2017 Sep 15;141(6):1130-1139.
Title: Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
Author: Wang, Nan|Lu, Yingchang|Khankari, Nikhil K|Long, Jirong|Li, Hong-Lan|Gao, Jing|Gao, Yu-Tang|Xiang, Yong-Bing|Shu, Xiao-Ou|Zheng, Wei
PMID: 28567967
Journal: Clin Epidemiol. 2018 Jan 19;10:143-152.
Title: Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score.
Author: Weigl, Korbinian|Chang-Claude, Jenny|Knebel, Phillip|Hsu, Li|Hoffmeister, Michael|Brenner, Hermann
PMID: 29403313
Journal: Int Immunopharmacol. 2018 Jun;59:375-383.
Title: Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-kappaB signaling pathways.
Author: Liu, You Dong|Ji, Cheng Bo|Li, Shan Bao|Yan, Feng|Gu, Qi Sheng|Balic, Jesse J|Yu, Liang|Li, Ji Kun
PMID: 29689497